Literature DB >> 34547467

Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A.

Claudia C Bippes1, Corina Kohler1, Esther Garcia-Tirado1, Reto Burri1, Tina Frauenknecht1, Marie-Apolline Gerard1, Marie Salat1, Roy Allenspach1, Cavit Agca1, Zongsong Wu1, Andrea Trost2, Barbara Bogner2, Peter Meyer3, Hendrik P N Scholl4, Herbert Reitsamer2, Josef Flammer3, Albert Neutzner5.   

Abstract

Cell-penetrating peptides (CPPs) hold great promise for intracellular delivery of therapeutic proteins. However, endosomal entrapment of transduced cargo is a major bottleneck hampering their successful application. While developing a transducible zinc finger protein-based artificial transcription factor targeting the expression of endothelin receptor A, we identified interaction between the CPP and the endosomal membrane or endosomal entanglement as a main culprit for endosomal entrapment. To achieve endosomal disentanglement, we utilized endosome-resident proteases to sever the artificial transcription factor from its CPP upon arrival inside the endosome. Using this approach, we greatly enhanced the correct subcellular localization of the disentangled artificial transcription factor, significantly increasing its biological activity and distribution in vivo. With rational engineering of proteolytic sensitivity, we propose a new design principle for transducible therapeutic proteins, helping CPPs attain their full potential as delivery vectors for therapeutic proteins.
Copyright © 2021 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ETRA/EDNRA; TAT peptide; artificial transcription factor; cathepsin; cell-penetrating peptide; endosomal entrapment; protein transduction; zinc finger

Mesh:

Substances:

Year:  2021        PMID: 34547467      PMCID: PMC8821953          DOI: 10.1016/j.ymthe.2021.09.018

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  40 in total

1.  Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors.

Authors:  Robert Morbitzer; Patrick Römer; Jens Boch; Thomas Lahaye
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-24       Impact factor: 11.205

2.  Nonisotopic quantitative analysis of protein-DNA interactions at equilibrium.

Authors:  A M Benotmane; M F Hoylaerts; D Collen; A Belayew
Journal:  Anal Biochem       Date:  1997-08-01       Impact factor: 3.365

3.  Bosentan therapy for pulmonary arterial hypertension.

Authors:  Lewis J Rubin; David B Badesch; Robyn J Barst; Nazzareno Galie; Carol M Black; Anne Keogh; Tomas Pulido; Adaani Frost; Sebastien Roux; Isabelle Leconte; Michael Landzberg; Gerald Simonneau
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

Review 4.  Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell.

Authors:  Peter Lönn; Steven F Dowdy
Journal:  Expert Opin Drug Deliv       Date:  2015-05-20       Impact factor: 6.648

5.  Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps.

Authors:  Joshua C Grieger; Richard J Samulski
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 6.  Endothelin-1 traps as a potential therapeutic tool: from diabetes to beyond?

Authors:  Arjun Jain; Charles Coffey; Vidhi Mehrotra; Josef Flammer
Journal:  Drug Discov Today       Date:  2019-08-05       Impact factor: 7.851

7.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis.

Authors:  Jehangir S Wadia; Radu V Stan; Steven F Dowdy
Journal:  Nat Med       Date:  2004-02-08       Impact factor: 53.440

8.  pBT, a novel vector for tetracycline-regulated yeast three-hybrid assay.

Authors:  Koki Moriyoshi
Journal:  Nucleic Acids Res       Date:  2008-12-02       Impact factor: 16.971

9.  RNA-guided gene activation by CRISPR-Cas9-based transcription factors.

Authors:  Pablo Perez-Pinera; D Dewran Kocak; Christopher M Vockley; Andrew F Adler; Ami M Kabadi; Lauren R Polstein; Pratiksha I Thakore; Katherine A Glass; David G Ousterout; Kam W Leong; Farshid Guilak; Gregory E Crawford; Timothy E Reddy; Charles A Gersbach
Journal:  Nat Methods       Date:  2013-07-25       Impact factor: 28.547

Review 10.  Mystery of Retinal Vein Occlusion: Vasoactivity of the Vein and Possible Involvement of Endothelin-1.

Authors:  Teruyo Kida
Journal:  Biomed Res Int       Date:  2017-08-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.